Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.350
-0.010 (-0.74%)
At close: Jan 21, 2026, 4:00 PM EST
1.330
-0.020 (-1.48%)
Pre-market: Jan 22, 2026, 7:48 AM EST
RANI Market Cap
RANI has a market cap or net worth of $164.05 million as of January 22, 2026. Its market cap has increased by 222.94% in one year.
Market Cap
164.05M
Enterprise Value
177.46M
1-Year Change
222.94%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on July 30, 2021, RANI's market cap has decreased from $206.13M to $164.05M, a decrease of -20.41%. That is a compound annual growth rate of -4.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 131.69M | - |
| Dec 31, 2025 | 131.69M | 188.57% |
| Dec 31, 2024 | 45.64M | -46.89% |
| Dec 29, 2023 | 85.92M | -41.09% |
| Dec 30, 2022 | 145.85M | -54.75% |
| Dec 31, 2021 | 322.29M | 56.36% |
| Jul 30, 2021 | 206.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Surrozen | 169.89M |
| Innate Pharma | 166.67M |
| Vaxart | 166.31M |
| Protalix BioTherapeutics | 164.06M |
| Century Therapeutics | 161.53M |
| Prelude Therapeutics | 160.68M |
| NeOnc Technologies Holdings | 160.66M |
| Corbus Pharmaceuticals Holdings | 159.81M |